Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin | 16 | 2007 | 1184 | 0.540 |
Why?
|
| Vitamin K 2 | 1 | 2015 | 2 | 0.470 |
Why?
|
| Osteoblasts | 1 | 2015 | 96 | 0.450 |
Why?
|
| Receptor, Insulin | 4 | 2007 | 60 | 0.430 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 201 | 0.420 |
Why?
|
| Insulin-Like Growth Factor I | 6 | 1997 | 116 | 0.410 |
Why?
|
| Osteogenesis | 1 | 2015 | 273 | 0.400 |
Why?
|
| Vitamin D | 1 | 2015 | 272 | 0.390 |
Why?
|
| Isoflavones | 2 | 2010 | 13 | 0.380 |
Why?
|
| Aorta, Thoracic | 2 | 2009 | 148 | 0.340 |
Why?
|
| Insulin-Like Growth Factor II | 4 | 1996 | 32 | 0.320 |
Why?
|
| Chordata, Nonvertebrate | 4 | 1996 | 6 | 0.320 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 436 | 0.310 |
Why?
|
| Vasodilation | 2 | 2009 | 91 | 0.310 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 132 | 0.280 |
Why?
|
| Amino Acid Sequence | 23 | 2007 | 1994 | 0.270 |
Why?
|
| RNA, Messenger | 14 | 2009 | 2020 | 0.260 |
Why?
|
| Protein Precursors | 8 | 1998 | 133 | 0.230 |
Why?
|
| Antigens, CD | 1 | 2007 | 476 | 0.220 |
Why?
|
| Molecular Sequence Data | 24 | 1998 | 2889 | 0.210 |
Why?
|
| Base Sequence | 21 | 1998 | 2207 | 0.210 |
Why?
|
| Biological Evolution | 8 | 1995 | 1019 | 0.190 |
Why?
|
| Subtilisins | 5 | 1995 | 27 | 0.190 |
Why?
|
| Cathepsin B | 5 | 1994 | 11 | 0.160 |
Why?
|
| Cloning, Molecular | 12 | 1998 | 577 | 0.160 |
Why?
|
| Animals | 34 | 2015 | 27973 | 0.150 |
Why?
|
| Salmon | 2 | 1997 | 7 | 0.150 |
Why?
|
| Receptor, IGF Type 1 | 2 | 1997 | 45 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2015 | 2827 | 0.140 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 1995 | 69 | 0.140 |
Why?
|
| Multigene Family | 4 | 1995 | 202 | 0.130 |
Why?
|
| Serine Endopeptidases | 3 | 1992 | 148 | 0.130 |
Why?
|
| Somatomedins | 3 | 1995 | 28 | 0.130 |
Why?
|
| Melanoma, Experimental | 3 | 1994 | 112 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 10 | 2010 | 888 | 0.120 |
Why?
|
| Islets of Langerhans | 4 | 1993 | 556 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 4 | 1993 | 406 | 0.120 |
Why?
|
| DNA | 11 | 1994 | 1260 | 0.120 |
Why?
|
| Sp7 Transcription Factor | 1 | 2015 | 1 | 0.120 |
Why?
|
| Osteocalcin | 1 | 2015 | 25 | 0.120 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 23 | 0.120 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2015 | 20 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 556 | 0.110 |
Why?
|
| Perciformes | 1 | 1996 | 41 | 0.110 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 128 | 0.110 |
Why?
|
| Endopeptidases | 2 | 1992 | 114 | 0.110 |
Why?
|
| Drug Synergism | 1 | 2015 | 313 | 0.110 |
Why?
|
| Calcitriol | 1 | 2015 | 173 | 0.110 |
Why?
|
| Gene Expression | 2 | 1997 | 1304 | 0.100 |
Why?
|
| Pancreatic Hormones | 1 | 1993 | 16 | 0.100 |
Why?
|
| Mice | 14 | 2015 | 12230 | 0.090 |
Why?
|
| Hydra | 1 | 1992 | 1 | 0.090 |
Why?
|
| In Vitro Techniques | 3 | 2009 | 944 | 0.090 |
Why?
|
| Proprotein Convertases | 5 | 1995 | 27 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1992 | 302 | 0.080 |
Why?
|
| Calcium | 1 | 2015 | 1173 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 2010 | 45 | 0.080 |
Why?
|
| Rats | 8 | 2009 | 4028 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 1996 | 402 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 1994 | 157 | 0.080 |
Why?
|
| Phytoestrogens | 1 | 2009 | 2 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 140 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2010 | 216 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2009 | 166 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2009 | 89 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 83 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 412 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 232 | 0.070 |
Why?
|
| Phytotherapy | 1 | 2009 | 137 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2010 | 3497 | 0.070 |
Why?
|
| Amyloid | 3 | 1994 | 104 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2015 | 1687 | 0.070 |
Why?
|
| Lipolysis | 1 | 2007 | 24 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2010 | 477 | 0.060 |
Why?
|
| Hartnup Disease | 1 | 2007 | 2 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2007 | 84 | 0.060 |
Why?
|
| Protein Binding | 2 | 2010 | 1526 | 0.060 |
Why?
|
| Dimerization | 1 | 2007 | 148 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 75 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2007 | 120 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2009 | 727 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1236 | 0.060 |
Why?
|
| Proinsulin | 5 | 1998 | 123 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 1996 | 287 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2007 | 206 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 638 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 1992 | 1260 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2007 | 296 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 550 | 0.060 |
Why?
|
| Cell Line | 3 | 2007 | 2458 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1996 | 379 | 0.050 |
Why?
|
| Glucose | 1 | 2007 | 686 | 0.050 |
Why?
|
| Introns | 4 | 1992 | 298 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1994 | 125 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 4 | 1998 | 958 | 0.050 |
Why?
|
| Genes | 3 | 1995 | 256 | 0.050 |
Why?
|
| Neuropeptides | 2 | 1995 | 113 | 0.050 |
Why?
|
| Cathepsins | 4 | 1991 | 22 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1994 | 119 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 752 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 1994 | 1980 | 0.050 |
Why?
|
| Zebrafish | 2 | 2010 | 339 | 0.040 |
Why?
|
| Hagfishes | 2 | 1992 | 5 | 0.040 |
Why?
|
| Male | 4 | 2015 | 44355 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 2 | 1991 | 87 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 1991 | 266 | 0.040 |
Why?
|
| Proprotein Convertase 2 | 3 | 1995 | 11 | 0.040 |
Why?
|
| Islet Amyloid Polypeptide | 3 | 1994 | 25 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1992 | 297 | 0.030 |
Why?
|
| Humans | 18 | 2010 | 93132 | 0.030 |
Why?
|
| Cartilage | 1 | 1997 | 71 | 0.030 |
Why?
|
| Blotting, Northern | 6 | 1994 | 239 | 0.030 |
Why?
|
| Phylogeny | 2 | 1995 | 1268 | 0.030 |
Why?
|
| Chickens | 2 | 1994 | 193 | 0.030 |
Why?
|
| Oligonucleotide Probes | 3 | 1991 | 36 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1991 | 194 | 0.030 |
Why?
|
| Exons | 3 | 1994 | 447 | 0.030 |
Why?
|
| TATA Box | 2 | 1994 | 9 | 0.030 |
Why?
|
| Furin | 2 | 1992 | 11 | 0.030 |
Why?
|
| Dogfish | 1 | 1995 | 1 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1995 | 35 | 0.030 |
Why?
|
| Species Specificity | 2 | 1995 | 683 | 0.030 |
Why?
|
| Larva | 1 | 1996 | 133 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1998 | 439 | 0.030 |
Why?
|
| Genome | 1 | 1997 | 407 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1990 | 279 | 0.030 |
Why?
|
| Mutation | 3 | 1990 | 4265 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1994 | 215 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 1992 | 1 | 0.020 |
Why?
|
| Lysosomes | 2 | 1991 | 123 | 0.020 |
Why?
|
| Pancreas | 1 | 1994 | 256 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 657 | 0.020 |
Why?
|
| RNA Precursors | 1 | 1992 | 73 | 0.020 |
Why?
|
| Gene Amplification | 2 | 1989 | 139 | 0.020 |
Why?
|
| Birds | 1 | 1993 | 172 | 0.020 |
Why?
|
| Hormones | 1 | 1992 | 136 | 0.020 |
Why?
|
| Intestines | 1 | 1994 | 433 | 0.020 |
Why?
|
| RNA | 2 | 1995 | 574 | 0.020 |
Why?
|
| Vertebrates | 1 | 1992 | 112 | 0.020 |
Why?
|
| Estrogen Receptor beta | 1 | 2010 | 26 | 0.020 |
Why?
|
| Carcinoma 256, Walker | 1 | 1990 | 4 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 1990 | 20 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 186 | 0.020 |
Why?
|
| Liver | 2 | 1995 | 1206 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2007 | 1229 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1991 | 259 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 155 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1992 | 663 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 774 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1994 | 1339 | 0.020 |
Why?
|
| Pancreatic Polypeptide | 1 | 1988 | 9 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 1988 | 58 | 0.020 |
Why?
|
| Swine | 1 | 1989 | 585 | 0.020 |
Why?
|
| Glucagon | 1 | 1988 | 114 | 0.020 |
Why?
|
| Macrophages | 1 | 1991 | 609 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2007 | 30 | 0.020 |
Why?
|
| Chromans | 1 | 2007 | 28 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2007 | 13 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 76 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 217 | 0.020 |
Why?
|
| Adipocytes | 1 | 2007 | 169 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 214 | 0.010 |
Why?
|
| Transcription, Genetic | 3 | 1994 | 1114 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 378 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 3431 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1994 | 107 | 0.010 |
Why?
|
| Mammals | 2 | 1996 | 259 | 0.010 |
Why?
|
| Leukocytes | 2 | 1994 | 210 | 0.010 |
Why?
|
| Cathepsin H | 2 | 1991 | 4 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1994 | 1022 | 0.010 |
Why?
|
| Obesity | 1 | 2007 | 1014 | 0.010 |
Why?
|
| Kidney | 2 | 1996 | 1093 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 290 | 0.010 |
Why?
|
| Genetic Variation | 2 | 1994 | 1416 | 0.010 |
Why?
|
| C-Peptide | 1 | 1976 | 184 | 0.010 |
Why?
|
| Genomic Library | 1 | 1994 | 30 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1994 | 65 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1995 | 209 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 348 | 0.010 |
Why?
|
| Luciferases | 1 | 1994 | 128 | 0.010 |
Why?
|
| DNA Probes | 1 | 1994 | 66 | 0.010 |
Why?
|
| Densitometry | 1 | 1994 | 23 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 981 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1994 | 109 | 0.010 |
Why?
|
| DNA Primers | 1 | 1994 | 528 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 164 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1996 | 1129 | 0.010 |
Why?
|
| Transfection | 1 | 1994 | 877 | 0.010 |
Why?
|
| Female | 3 | 2007 | 48542 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1994 | 601 | 0.010 |
Why?
|
| Cathepsin L | 1 | 1991 | 7 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1991 | 40 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1991 | 53 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1991 | 73 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1991 | 83 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1991 | 279 | 0.000 |
Why?
|
| Molecular Biology | 1 | 1990 | 83 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1989 | 162 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1994 | 825 | 0.000 |
Why?
|
| Cats | 1 | 1989 | 281 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1976 | 762 | 0.000 |
Why?
|
| Aspartic Acid | 1 | 1988 | 62 | 0.000 |
Why?
|
| DNA Polymerase I | 1 | 1988 | 9 | 0.000 |
Why?
|
| Americas | 1 | 1988 | 19 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 60 | 0.000 |
Why?
|
| Reference Values | 1 | 1989 | 603 | 0.000 |
Why?
|
| Histidine | 1 | 1988 | 69 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1989 | 672 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 429 | 0.000 |
Why?
|
| DNA Replication | 1 | 1988 | 168 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1988 | 1581 | 0.000 |
Why?
|
| Models, Biological | 1 | 1992 | 1768 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 2337 | 0.000 |
Why?
|